Dyne Therapeutics DYN
NASDAQ DYN
$15.82 -0.29 (-1.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Invested Capital (2020)

Updated

Dyne Therapeutics (DYN) reported Invested Capital of $376.78 million for Q3 2020.

Analysis

Dyne Therapeutics (DYN) Invested Capital (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Dyne Therapeutics 2.67 Bn 2.67 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 376.78 Mn
API Access

Dyne Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=DYN&period=max&api_key=YOUR_API_KEY